Please login to the form below

Not currently logged in
Email:
Password:

Communicating with payers to improve patient access

A transforming NHS brings with it many opportunities. Working with payers to put patients at the heart of everything while reducing costs is fundamental to success.

Triducive Tim WarrenThe emergence of the 'empowered patient' is quickly changing how healthcare decisions are made. Forward-thinking pharma companies are at the forefront of this change, and so too are payers who also face the challenge of making the healthcare they commission patient-centric.

A shared focus on the patient
With this shared focus on the patient, savvy pharma companies are refocusing efforts on working collaboratively with payers and other stakeholders to develop solutions, rather than just sell products.

With commissioners looking to engage patients in service design and health delivery decisions, pharma is well-placed to support this engagement by working alongside clinicians and patient groups. Some regions and localities are doing it better than others and the innovators and early adopters are a fertile market for the industry.

Develop ICPs to benchmark health outcomes
A key part of patient-centricity is developing strategies that add value to the touchpoints of the patients' journeys. Truly Integrated Care Pathways (ICPs) provide a way of benchmarking and measuring patient outcomes, while ensuring patients have equitable access to best practice standards of care.

By doing this type of work credibly and thoroughly, pharma can help payers redesign care pathways to ensure that the focus remains firmly on the patients and on improving their health outcomes through implementable steps.

Pharma has an important role to play in working with payers and other decision-makers to transform the NHS into a more patient-centric and cost-effecient organisation

Utilise real-world data to demonstrate outcomes
With payers increasingly imposing value-based pricing and an increased ability to track health outcomes and collect real-world data, being able to demonstrate patient-centred outcomes is more important for pharma than ever before. It is vital that pharmaceutical companies harness this data to meet the payers' demands for an even sharper accountability for improving patient outcomes.

Become a 'payer partner', not just a vendor
In the shifting NHS landscape, pharmaceutical companies need to become more like business partners - working alongside payers and wider networks to support their growth and development in a way more akin to a business-to-business (B2B) relationship - rather than simply a provider.

Help to implement change
Pharma has an important role to play in working with payers and other decision-makers to transform the NHS into a more patient-focused and cost-efficient organisation, but it must be done in a collaborative and strategic fashion.

Kotter's 8-step change model provides a helpful framework for understanding the process of change that the NHS is currently going through.
Effective pharma key account management involves planning activities according to the 'change step' their local health economy is going through.

Old models of pharma marketing are becoming less valid and pharma needs to consider 'what' it does with the NHS to convey value, rather just relying on 'how' it does it.

Triducive thought leader graphic

Support payers to motivate patient populations
Payers know that patient education and support will motivate patient persistence with treatments and thus drive health outcomes. Effective patient engagement helps to build confidence that the time, effort and resources invested in making changes across a local health economy will not be wasted - thus supporting the need to address the issue of medicines wastage across the NHS.

Pharma is well-placed to support these approaches (eg working with suitable clinicians and credible patient groups) and local payers often appreciate relevant help.

Don't over-promise
The NHS is continually transforming, making it barely recognisable from the health service a decade ago. While pharma is well-placed to support the NHS through this evolution, the industry must be careful not to over-promise and under-deliver.

Pharma needs to support the NHS in relevant areas where it can make a tangible difference that results in achievable and measurable outcomes.

Six steps to success

  1. Remember that payers need to be patient-centric - don't just pay lip-service, put patients at the heart of your payer communications
  2. Partner to innovate - seek more opportunities for Joint Working
  3. Support the NHS in its transition to new models and ways of working
  4. Think local - understand and target the local health economy. Remember that the only 'national' element of the NHS is its name
  5. Support payers to educate their patient populations - help local patients persist with the treatments they receive
  6. Understand your payer archetypes and communicate in a relevant way in order to resonate.

Tim Warren is managing director at Triducive - a leading health and payer communication consultancy.  For more information, see www.triducive.co.uk

In association with Triducive

1st November 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...

Infographics